3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Completed
18
Unknown
9
Terminated
3
Suspended
1
Sponsor Class
UNKNOWN
1
OTHER
1
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Stomach Neoplasms
3
Pancreatic Neoplasms
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Interventions
Capecitabine
27
pembrolizumab
19
Oxaliplatin
19
Fluorouracil
17
Cisplatin
17
Trastuzumab
14
Docetaxel
14
Leucovorin
11
Paclitaxel
8
Irinotecan
8
S 1 (combination)
7
Epirubicin
6
Cyclophosphamide
5
tegafur-gimeracil-oteracil
4
aldesleukin
4
Hyperthermic Intraperitoneal Chemotherapy
4
titanium silicide
3
spartalizumab
3
fludarabine phosphate
3
fludarabine
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Ramucirumab
3
Nivolumab
3
Indocyanine Green
3
Gemcitabine
3
Carboplatin
3
Albumin-Bound Paclitaxel
3
Ado-Trastuzumab Emtansine
3
vistusertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Terminated
×
Stomach Neoplasms
×
titanium silicide
×
Clear all
NCT01285557
2024-09-19
DIGEST
Taiho Oncology, Inc.
Phase 3
Terminated
361 enrolled
18 charts
NCT02191566
2022-12-08
SOHUG
Kangbuk Samsung Hospital
Phase 2
Terminated
8 enrolled
NCT01980810
2016-06-14
GC-A-003
ChineseAMS
Phase 2
Terminated
36 enrolled